Form 4 for OCGN Ocugen, Inc.
Accepted 2025-01-06 00:00:00 ET · period of report 2025-01-02 · accession 0001062993-25-000405 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-06 | 2025-01-03 | OCGN | Musunuri Shankar | CEO, Dir | F - Tax | $0.89 | -177.1K | 1.83M | -9% | -$157.7K |
| D | 2025-01-06 | 2025-01-02 | OCGN | Musunuri Shankar | CEO, Dir | A - Grant | $0.00 | +1.83M | 1.83M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-03 | F | D | 177,146 | $0.89 | 1,832,723 | D | — | — | |
| 2 | Derivative | Option (Right to Buy) | 2025-01-02 | A | A | 1,827,485 | $0.00 | 1,827,485 | D | $0.9 · — to 2035-01-02 | 1,827,485 Common Stock | (F2) The option vests annually in equal installments over three years commencing on January 2, 2026, subject to continued service with the Issuer on the applicable vesting dates. |